These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28586138)

  • 1. Postoperative radiotherapy dose requirement in standard combined-modality practice for head and neck squamous cell carcinoma: Analysis of salient surgical and radiotherapy parameters in 2 cohorts.
    Mohanti BK; Thakar A; Kaur J; Bahadur S; Malik M; Gandhi AK; Bhasker S; Sharma A
    Head Neck; 2017 Sep; 39(9):1788-1796. PubMed ID: 28586138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.
    Langendijk JA; Slotman BJ; van der Waal I; Doornaert P; Berkof J; Leemans CR
    Cancer; 2005 Oct; 104(7):1408-17. PubMed ID: 16130134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated postoperative radiotherapy with weekly concomitant boost in patients with locally advanced head and neck cancer.
    Zouhair A; Azria D; Pasche P; Stupp R; Chevalier J; Betz M; Mirimanoff RO; Ozsahin M
    Radiother Oncol; 2004 Feb; 70(2):183-8. PubMed ID: 15028406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical radiotherapy in head and neck squamous cell carcinoma: an analysis of prognostic and therapeutic factors.
    Dinshaw KA; Agarwal JP; Ghosh-Laskar S; Gupta T; Shrivastava SK
    Clin Oncol (R Coll Radiol); 2006 Jun; 18(5):383-9. PubMed ID: 16817329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head and neck squamous cell carcinoma: the role of post-operative adjuvant radiotherapy.
    Dinshaw KA; Agarwal JP; Laskar SG; Gupta T; Shrivastava SK; Cruz AD
    J Surg Oncol; 2005 Jul; 91(1):48-55. PubMed ID: 15999358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome and patterns of recurrence of head and neck squamous cell carcinoma with a limited field of postoperative radiotherapy.
    Goto Y; Kodaira T; Furutani K; Tachibana H; Tomita N; Ito J; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Hasegawa Y
    Jpn J Clin Oncol; 2013 Jul; 43(7):719-25. PubMed ID: 23667153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
    Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
    J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry.
    Vallard A; Guy JB; Mengue Ndong S; Vial N; Rivoirard R; Auberdiac P; Méry B; Langrand-Escure J; Espenel S; Moncharmont C; Ben Mrad M; Diao P; Goyet D; Magné N
    Head Neck; 2016 Jul; 38(7):1028-34. PubMed ID: 26855006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
    Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
    J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: Improved survival with the addition of adjuvant radiotherapy.
    Wang JT; Palme CE; Morgan GJ; Gebski V; Wang AY; Veness MJ
    Head Neck; 2012 Nov; 34(11):1524-8. PubMed ID: 22109745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment.
    Erkan S; Savundra JM; Wood B; Acharya AN; Rajan GP
    Head Neck; 2017 Jul; 39(7):1280-1286. PubMed ID: 28474414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
    Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
    Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning.
    Chen AM; Daly ME; Cui J; Mathai M; Benedict S; Purdy JA
    Head Neck; 2014 Nov; 36(11):1541-6. PubMed ID: 23996502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
    Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
    BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive impact of radiation dose on disease free survival and locoregional control in postoperative radiotherapy for squamous cell carcinoma of esophagus.
    Moon S; Kim H; Chie E; Kim J; Park C
    Dis Esophagus; 2009; 22(4):298-304. PubMed ID: 19021683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of postoperative radiation therapy for regional control after dissection in head and neck squamous cell carcinoma cases.
    Li XM; Di B; Shang YD; Tao ZF; Cheng JM; He ZG
    Asian Pac J Cancer Prev; 2013; 14(7):4273-8. PubMed ID: 23991989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of average weekly dose of radiation during radiotherapy alone or chemoradiotherapy in head and neck cancer.
    Dragovic AF; Bonner JA; Spencer SA; Nabell LM; Carroll WR; Caudell JJ
    Head Neck; 2011 Nov; 33(11):1551-6. PubMed ID: 21990218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers.
    George JR; Yom SS; Wang SJ
    JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1118-26. PubMed ID: 24051518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection.
    Patel SA; Qureshi MM; Mak KS; Sahni D; Giacalone NJ; Ezzat W; Jalisi S; Truong MT
    Head Neck; 2017 Jul; 39(7):1371-1377. PubMed ID: 28370725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.